VANGUARD GROUP INC - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 75 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 443.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$8,873,864
-18.2%
2,808,185
+0.2%
0.00%
Q2 2023$10,843,376
+37.8%
2,801,906
-1.3%
0.00%
Q1 2023$7,867,357
+100.9%
2,840,201
+30.6%
0.00%
Q4 2022$3,915,677
-15.1%
2,175,376
-0.1%
0.00%
Q3 2022$4,614,000
-21.3%
2,176,689
-0.2%
0.00%
Q2 2022$5,865,000
-42.5%
2,180,320
-7.3%
0.00%
Q1 2022$10,207,000
+53.3%
2,351,935
+83.0%
0.00%
Q4 2021$6,657,000
+85.1%
1,285,297
+119.4%
0.00%
Q3 2021$3,597,000585,8620.00%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders